Literature DB >> 2573555

Insulin prevention of altered muscarinic receptor-G protein coupling in diabetic rat atria.

R S Aronstam1, G O Carrier.   

Abstract

Right atria from rats rendered diabetic by injection of streptozocin (STZ-D) for 8-10 wk are supersensitive to the negative chronotropic effects of muscarinic agonists but have decreased levels of muscarinic receptors and acetylcholinesterase activity. Insulin treatment completely prevents the development of these changes. The proportion of atrial muscarinic receptors displaying high-affinity agonist binding is lower in STZ-D rats; however, the sensitivity of high-affinity agonist binding to regulation by a guanine nucleotide (5'-guanylylimidodiphosphate) is greater in atria from diabetic rats. Again, insulin treatment eliminates these differences. These findings indicate that alterations in atrial muscarinic systems in STZ-D rats are a consequence of the elaboration of the diabetic state and suggest that an alteration of functional muscarinic receptor-G protein coupling contributes to the altered physiological responsiveness of the heart in diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573555     DOI: 10.2337/diab.38.12.1611

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

1.  Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.

Authors:  S E Litwin; T E Raya; P G Anderson; S Daugherty; S Goldman
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes.

Authors:  P D Morrison; M W Mackinnon; J T Bartrup; P G Skett; T W Stone
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

3.  Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment.

Authors:  Cimen Karasu
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.